Font Size: a A A
Keyword [Immune Checkpoint]
Result: 161 - 180 | Page: 9 of 10
161. Studies On Combination Of The LAG-3 Antibody And CGAMP Used For The Cancer Treatment
162. Preparation Of PD-L1 Monoclonal Antibody And Its Antitumor Activity In Humanized Mouse Model
163. Meta Analysis Of Efficacy And Safety Of PD-1/PD-L1 Or CTLA-4 Inhibitors Combined With Chemotherapy In The Treatment Of Non-small Cell Lung Cancer
164. Manipulation Of TAMs Functions To Facilitate The Immune Therapy Effects Of PD-1 Antibody
165. Evaluation Of Synergistic Antitumor Effect Based On Small Molecule Immune Inhibitor BMS And Photosensitizer Ce6
166. Analysis Of Characteristics,predictive Factors And Correlation With Survival Outcomes Of Immunotherapy-related Adverse Events
167. Expression Of Immune Checkpoint Molecules TIM-3,PD-1 And Its Ligand PD-L1 In DLBCL And Their Bioinformatics Analysis In Tumor Immunity
168. The Predictive Role Of Hematological Indicators In The Efficacy Of Immune Checkpoint Inhibitors In Patients With NSCLC
169. Real-world Study On SII/ALB Ratio Predicting The Efficacy Of Immune Checkpoint Inhibitors In The Treatment Of Malignant Tumors
170. Study On The Correlation Between The Clinical Characteristics Of Advanced Non-small Cell Lung Cancer And The Prognosis Of Immunotherapy
171. Study On The Correlation Between The Efficacy Of Immune Markers And PD-1/PD-L1 Inhibitors In The Treatment Of Lung Cancer
172. Clinical Observation Of Radioactive Iodine?125 Seeds Implantation Combined With Immune Checkpoint Inhibitors In The Treatment Of Advanced Non-small Cell Lung Cancer
173. The Effect Of Smoking History On The Efficacy Of Immune Checkpoint Inhibitors In Advanced Non-Small Cell Lung Cancer:a Meta-Analysis
174. Association Between Blood-based Tumor Mutation Burden And Efficacy Of Immune Checkpoint Inhibitors:A Meta-analysis
175. Analysis Of The Efficacy And Safety Of Immune Checkpoint Inhibitors In The Treatment Of Advanced Non-small Cell Lung Cancer
176. Based On Literature And Real World Studies,the Study On The Clinical Efficacy Of The Traditional Chinese Medicine For Yiqi Qutan Prescription Combined With PD1/PD-L1 Monoclonal Antibody In The Treatment Of Advanced Lung Cancer
177. Immunohistochemical Double Staining Technique To Screen Patients With Non-small Cell Lung Cancer Suitable For PD-L1 Inhibitor Therapy
178. Exsomal MicroRNA Profile And Biomarker To Predict Treatment Of Bone Metastasis In NSCLC
179. Novel Photo-responsive Gels For Combination Of Phototherapy And Immunotherapy For Postsurgical Cancer Treatment
180. Studies On A PH-Responsive Pickering Nanoemulsion For Specified Spatial Delivery Of Immune Checkpoint Inhibitor And DOX
  <<First  <Prev  Next>  Last>>  Jump to